Physical activity support for prostate cancer patients
Title Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients - ACTI-PAIR 2 Multicenter, Randomized Stepped-wedge Study
This study is trying to see if a personalized support program can help prostate cancer patients become more active by encouraging them to walk more, which may improve their health and reduce cancer risks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 850 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne Academic / other |
| Locations | 25 sites (Chambéry and 24 other locations) |
| Trial ID | NCT05739565 on ClinicalTrials.gov |
What this trial studies
This study aims to improve physical activity levels among prostate cancer patients by implementing a personalized intervention program that combines support from health professionals and peers. The program encourages patients to engage in at least 150 minutes of brisk walking per week, which is linked to reduced cancer mortality and recurrence. By utilizing physical activity support devices and personalized coaching, the study seeks to initiate and sustain regular physical activity over the long term. The intervention targets patients who are currently insufficiently active and have been diagnosed with prostate cancer for at least one year.
Who should consider this trial
Good fit: Ideal candidates for this study are prostate cancer patients aged 18 and older who are currently inactive and have been diagnosed for at least one year.
Not a fit: Patients undergoing treatment for prostate cancer (except hormone therapy) or those with significant comorbidities that prevent physical activity may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life and survival rates for prostate cancer patients through increased physical activity.
How similar studies have performed: Previous studies have shown that personalized physical activity interventions can be effective, but this approach aims to establish long-term sustainability, making it a novel contribution to the field.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients: * Age ≥ 18 years * Diagnosed with prostate cancer for at least 1 year * PA practice \< 150 minutes per week (considered inactive according to WHO) * Affiliated or entitled to a social security scheme * Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study Exclusion Criteria: For patients: * Undergoing treatment (except hormone therapy) * Significant comorbidities contraindicating the practice of physical activity: associated cardiac pathologies, respiratory pathologies, disabling joint pathologies * Deprived of liberty or under guardianship
Where this trial is running
Chambéry and 24 other locations
- Activité Physique Adaptée - CDOS Savoie — Chambéry, France (Not_yet_recruiting)
- CH Chambéry — Chambéry, France (Not_yet_recruiting)
- Activité Physique Adaptée - DAHLIR 63 — Clermont-Ferrand, France (Not_yet_recruiting)
- CHU Clermont-Ferrand - ONCOLOGIE — Clermont-Ferrand, France (Not_yet_recruiting)
- CHU Clermont-Ferrand - Urologie — Clermont-Ferrand, France (Not_yet_recruiting)
- Activité Physique Adaptée - CDOS Isère — Grenoble, France (Not_yet_recruiting)
- CHU Grenoble - Urologie — Grenoble, France (Not_yet_recruiting)
- Activité Physique Adaptée - DAHLIR 43 — Le Puy-en-Velay, France (Not_yet_recruiting)
- CH Le Puy en Velay — Le Puy-en-Velay, France (Not_yet_recruiting)
- HCL - Hôpital Edouard Herriot — Lyon, France (Not_yet_recruiting)
- HCL - Hôpital Croix Rousse — Lyon, France (Not_yet_recruiting)
- Activité Physique Adaptée - DAHLIR 69 — Lyon, France (Not_yet_recruiting)
- CLB - Oncologie — Lyon, France (Not_yet_recruiting)
- CLB - Radiothérapie — Lyon, France (Not_yet_recruiting)
- HCL - CH Lyon Sud — Lyon, France (Not_yet_recruiting)
- Activité Physique Adaptée - CDOS Ardèche — Privas, France (Not_yet_recruiting)
- CH Roanne — Roanne, France (Not_yet_recruiting)
- Activité Physique Adaptée - DAPAP 42 — Saint-Etienne, France (Not_yet_recruiting)
- CHU Saint-Etienne - Oncologie — Saint-Etienne, France (Recruiting)
- CHU Saint-Etienne - Radiothérapie — Saint-Etienne, France (Not_yet_recruiting)
- Hôpital Privé de la Loire — Saint-Etienne, France (Recruiting)
- Clinique du parc — Saint-Priest-en-Jarez, France (Not_yet_recruiting)
- Activité Physique Adaptée - CDOS Drôme — Valence, France (Not_yet_recruiting)
- Hôpitaux Drôme Nord - Valence — Valence, France (Not_yet_recruiting)
- Radiologie Drôme-Ardèche - Valence — Valence, France (Not_yet_recruiting)
Study contacts
- Principal investigator: David HUPIN, MD PhD — CHU de Saint-Etienne
- Study coordinator: Hupin David, Md
- Email: David.Hupin@chu-st-etienne.fr
- Phone: (0)477828413
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.